CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
Do-Youn Oh, Se-Hoon Lee, Sae-Won Han, Mi-Jung Kim, Tae-Min Kim, Tae-You Kim, Dae Seog Heo, Miyuki Yuasa, Yasuo Yanagihara, Yung-Jue Bang
Cancer Research and Treatment. 2015;47(4):607-615.   Published online 2015 February 26    DOI: https://doi.org/10.4143/crt.2014.249

Excel Download

Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
Cancer Research and Treatment. 2015;47(4):607-615   Crossref logo
Link1 Link2 Link3

Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors
Cancer Chemotherapy and Pharmacology. 2014;74(1):125-130   Crossref logo
Link1 Link2 Link3 Link4

Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma
Hepatology Research. 2015;45(13):1283-1291   Crossref logo
Link1 Link2

Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma
Cancer Research and Treatment. 2019;51(2):510-518   Crossref logo
Link1 Link2 Link3

1448 ORAL Molecular pharmacodynamic (MPD) phase I study with serial tumor and skin biopsies of the oral mTOR inhibitor Everolimus (E, RAD001) at different doses and schedules in patients (pts) with advanced solid tumors
European Journal of Cancer Supplements. 2005;3(2):419   Crossref logo
Link1 Link2

238 oral Phase I study of combined treatment with the oral alkyl-phospholipid (APL) perifosine and radiation in patients with advanced solid tumors
Radiotherapy and Oncology. 2004;73:S108   Crossref logo
Link1 Link2

A phase I and pharmacokinetic study of the farnesyl transferase inhibitor, CP-609,754 in patients with advanced solid tumors
European Journal of Cancer. 2002;38:S56   Crossref logo
Link1 Link2

Phase I study of roniciclib (BAY1000394), an oral CDK inhibitor in Japanese patients with advanced solid tumors
Annals of Oncology. 2016;27:vii87-vii88   Crossref logo
Link1 Link2 Link3

Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumors
Investigational New Drugs. 2019;38(4):1175-1185   Crossref logo
Link1 Link2 Link3

Final Results of Phase I Study of the Oral Class I PI3K Inhibitor CH5132799 in Patients with Advanced Solid Tumours
Annals of Oncology. 2013;24:i33   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.